Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care

被引：0
|
作者：
Munoz-Martinez, Sergio [1 ,2 ]
Jimenez-Masip, Alba [1 ,3 ]
Pericas, Juan M. [1 ,3 ,4 ]
机构：
[1] Vall dHebron Hosp Univ, Liver Unit, Vall dHebron Inst Recerca VHIR, Liver Unit, Pg Vall dHebron 119-129, Barcelona 08035, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2024年 / 13卷 / 01期
关键词：
Metabolic-dysfunction associated steatotic liver disease (MASLD); advanced fibrosis; type 2 diabetes (T2D); non-invasive tests (NITs); OUTCOMES; NAFLD;
D O I：
10.21037/hbsn-23-563
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：128 / 131
页数：4
相关论文
共 50 条
  • [31] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
  • [32] PRESENCE OF SARCOPENIA AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF ADVANCED HEPATIC FIBROSIS
    Habig, Gregory
    Smaltz, Christa
    Bilello, Justin
    Monsuruddin, Shahir A.
    Guglielmo, Flavius
    Halpern, Ethan J.
    Halegoua-De Marzio, Dina
    GASTROENTEROLOGY, 2024, 166 (05) : S475 - S476
  • [33] Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study
    Kouvari, Matina
    Valenzuela-Vallejo, Laura
    Guatibonza-Garcia, Valentina
    Verrastro, Ornella
    Axarloglou, Evangelos
    Mylonakis, Sophia C.
    George, Jacob
    Papatheodoridis, Georgios
    Mingrone, Geltrude
    Mantzoros, Christos S.
    CLINICAL NUTRITION, 2024, 43 (12) : 101 - 108
  • [34] Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma
    El-Kassas, Mohamed
    Othman, Heba A.
    Elbadry, Mohamed
    Alswat, Khalid
    Yilmaz, Yusuf
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [35] DEGREE OF METABOLIC DYSFUNCTION IS LINKED TO STEATOHEPATITIS (MASH), FIBROSIS, AND HIGHER CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Kim, David
    Abboud, Yazan
    Ismail, Mohamed
    Goyal, Ritik Mahaveer
    Pyrsopoulos, Nikolaos
    Kim, Hyunseok
    Hajifathalian, Kaveh
    Al-Khazraji, Ahmed
    HEPATOLOGY, 2024, 80 : S441 - S442
  • [36] Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Schreiner, Andrew D.
    Zhang, Jingwen
    Moran, William P.
    Koch, David G.
    Marsden, Justin
    Bays, Chloe
    Mauldin, Patrick D.
    Gebregziabher, Mulugeta
    ENDOCRINE PRACTICE, 2024, 30 (11) : 1015 - 1022
  • [37] Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease is Independently Associated with Reduced Kidney Function
    Karim, Gres
    Villarroel, Carolina
    Giri, Dewan
    Weisberg, Ilan
    Dinani, Amreen
    JOURNAL OF HEPATOLOGY, 2024, 80 : S487 - S487
  • [38] The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Shinomiya, Ryo
    Miyake, Takanori
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Kida, Yoshifumi
    Okada, Yasuyuki
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1587 - 1598
  • [39] Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kumar, Ashish
    Arora, Anil
    Sharma, Praveen
    Jan, Shayesta
    Ara, Ishrat
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [40] The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Sasada, Takafumi
    Iino, Chikara
    Sato, Satoshi
    Tateda, Tetsuyuki
    Igarashi, Go
    Yoshida, Kenta
    Sawada, Kaori
    Mikami, Tatsuya
    Nakaji, Shigeyuki
    Sakuraba, Hirotake
    Fukuda, Shinsaku
    NUTRIENTS, 2024, 16 (17)
12345